Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,292 | 1,325 | 92.3% |
| Education | $1,434 | 11 | 7.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,176 | 273 | $0 (2024) |
| PFIZER INC. | $1,686 | 167 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,456 | 84 | $0 (2024) |
| Summit Surgical Corp. | $1,200 | 1 | $0 (2022) |
| ABBVIE INC. | $1,095 | 85 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,009 | 81 | $0 (2024) |
| Lilly USA, LLC | $998.78 | 65 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $769.76 | 69 | $0 (2024) |
| Astellas Pharma US Inc | $690.31 | 35 | $0 (2024) |
| Amarin Pharma Inc. | $574.12 | 63 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,623 | 150 | Novo Nordisk Inc ($489.81) |
| 2023 | $2,572 | 166 | Novo Nordisk Inc ($577.47) |
| 2022 | $3,575 | 177 | Summit Surgical Corp. ($1,200) |
| 2021 | $2,576 | 189 | AbbVie Inc. ($312.40) |
| 2020 | $1,962 | 171 | Novo Nordisk Inc ($349.36) |
| 2019 | $1,819 | 160 | Novo Nordisk Inc ($403.64) |
| 2018 | $1,850 | 164 | Novo Nordisk Inc ($422.69) |
| 2017 | $1,749 | 159 | Janssen Pharmaceuticals, Inc ($310.82) |
All Payment Transactions
1,336 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Insomnia | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/26/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Central Nervous System | ||||||
| 11/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.56 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: VACCINE | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Central Nervous System | ||||||
| 11/07/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Respiratory | ||||||
| 10/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: VACCINE | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,330 | 4,790 | $403,082 | $297,044 |
| 2022 | 25 | 2,007 | 4,598 | $326,215 | $233,427 |
| 2021 | 27 | 1,998 | 4,474 | $310,808 | $223,849 |
| 2020 | 29 | 2,227 | 4,088 | $292,174 | $186,210 |
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 429 | 1,127 | $107,065 | $64,451 | 60.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 179 | 184 | $55,200 | $51,790 | 93.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 355 | 355 | $46,150 | $43,718 | 94.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 103 | 428 | $36,380 | $21,612 | 59.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 1,260 | $27,661 | $21,328 | 77.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 245 | $33,075 | $20,515 | 62.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 206 | 207 | $16,136 | $15,682 | 97.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 92 | 106 | $19,080 | $14,550 | 76.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 256 | 259 | $6,734 | $6,599 | 98.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 44 | 71 | $8,165 | $5,536 | 67.8% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 30 | 45 | $6,750 | $5,271 | 78.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 179 | 184 | $4,784 | $4,688 | 98.0% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 39 | 49 | $7,595 | $4,122 | 54.3% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 20 | 25 | $5,500 | $3,421 | 62.2% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 36 | 60 | $7,200 | $3,104 | 43.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $3,060 | $2,081 | 68.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $3,400 | $2,078 | 61.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,210 | $2,055 | 93.0% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 56 | 56 | $1,896 | $1,769 | 93.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 15 | 15 | $2,175 | $1,492 | 68.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 14 | $910.00 | $599.90 | 65.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 24 | $624.00 | $257.04 | 41.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $1,020 | $186.15 | 18.3% |
| 90471 | Administration of vaccine | Office | 2023 | 12 | 12 | $312.00 | $136.53 | 43.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 422 | 1,086 | $103,170 | $62,512 | 60.6% |
About Dr. Thomas Keller, D.O
Dr. Thomas Keller, D.O is a Internal Medicine healthcare provider based in Hanover, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073587515.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Keller, D.O has received a total of $18,726 in payments from pharmaceutical and medical device companies, with $2,623 received in 2024. These payments were reported across 1,336 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($17,292).
As a Medicare-enrolled provider, Keller has provided services to 8,562 Medicare beneficiaries, totaling 17,950 services with total Medicare billing of $940,530. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Hanover, PA
- Active Since 02/13/2006
- Last Updated 07/02/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073587515
Products in Payments
- Ozempic (Drug) $1,458
- FARXIGA (Drug) $662.42
- Rybelsus (Drug) $638.40
- ELIQUIS (Drug) $584.63
- Vascepa (Drug) $574.12
- VRAYLAR (Drug) $521.20
- ENTRESTO (Drug) $493.89
- TRELEGY ELLIPTA (Drug) $482.33
- BREZTRI (Drug) $456.59
- CHANTIX (Drug) $421.31
- XARELTO (Drug) $382.28
- INVOKANA (Drug) $381.46
- UBRELVY (Drug) $372.46
- JARDIANCE (Drug) $360.49
- TRULICITY (Drug) $349.86
- MOUNJARO (Drug) $278.63
- SHINGRIX (Biological) $266.82
- Victoza (Drug) $265.90
- NURTEC ODT (Drug) $263.44
- QULIPTA (Drug) $246.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hanover
Dr. Joanne Chan, M.d, M.D
Internal Medicine — Payments: $18,763
Ms. Moushumi Kundu, Md, MD
Internal Medicine — Payments: $13,036
Dr. David Gilbert, Do, DO
Internal Medicine — Payments: $5,912
Dr. Nahid Kennedy, D.o, D.O
Internal Medicine — Payments: $4,627
Gurpal Singh, Md, MD
Internal Medicine — Payments: $4,451
Vipul Shah, Md, MD
Internal Medicine — Payments: $3,034